Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Scripps Florida Scientists Uncover Potential… >

Scripps Florida Scientists Uncover Potential Drug Target to Block Cell Death in Parkinson's Disease

Published: January 10, 2013.
Released by Scripps Research Institute  

JUPITER, FL, January 10, 2013 – Oxidative stress is a primary villain in a host of diseases that range from cancer and heart failure to Alzheimer's disease, Amyotrophic Lateral Sclerosis and Parkinson's disease. Now, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that blocking the interaction of a critical enzyme may counteract the destruction of neurons associated with these neurodegenerative diseases, suggesting a potential new target for drug development.

These findings appear in the January 11, 2013 edition of The Journal of Biological Chemistry.

During periods of cellular stress, such as exposure to UV radiation, the number of highly reactive oxygen-containing molecules can increase in cells, resulting in serious damage. However, relatively little is known about the role played in this process by a number of stress-related enzymes.

In the new study, the TSRI team led by Professor Philip LoGrasso focused on an enzyme known as c-jun-N-terminal kinase (JNK). Under stress, JNK migrates to the mitochondria, the part of the cell that generates chemical energy and is involved in cell growth and death. That migration, coupled with JNK activation, is associated with a number of serious health issues, including mitochondrial dysfunction, which has long been known to contribute to neuronal death in Parkinson's disease.

The new study showed for the first time that the interaction of JNK with a protein known as Sab is responsible for the initial JNK localization to the mitochondria in neurons. The scientists also found blocking JNK mitochondrial signaling by inhibiting JNK interaction with Sab can protect against neuronal damage in both cell culture and in the brain.

In addition, by treating JNK with a peptide inhibitor derived from a mitochondrial membrane protein, the team was able to induce a two-fold level of protection of neurons in the substantia nigra pars compacta, the brain region devastated by Parkinson's disease.

The study noted that this inhibition leaves all other cell signaling intact, which could mean potentially fewer side effects in any future therapies.

"This may be a novel way to prevent neuron degeneration," said LoGrasso. "Now we can try to make compounds that block that translocation and see if they're therapeutically viable."




The above story is based on materials provided by Scripps Research Institute.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Science 
3/12/11 
★ 
Finding Shows Potential Way to Protect Neurons in Parkinson's, Alzheimer's, ALS
SAN ANTONIO (March 11, 2011) — Cell biologists pondering the death of neurons — brain cells — said today …
Nad+ 
2/12/15 
Finding Points to Possible Mechanism Underpinning Alzheimer's And Parkinson's Diseases
JUPITER, FL - February 12, 2015 - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have …
Neurons 
10/1/12 
Potential New Class of Drugs Blocks Nerve Cell Death
Diseases that progressively destroy nerve cells in the brain or spinal cord, such as Parkinson's disease (PD) and amyotrophic …
Reddy 
12/26/13 
Antioxidant Drug Knocks Down Multiple Sclerosis-like Disease in Mice
PORTLAND, Ore. — Researchers at Oregon Health & Science University have discovered that an antioxidant designed more than a …
Vcp 
3/14/13 
Mutations in VCP Gene Implicated in a Number of Neurodegenerative Diseases
New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of …
Disease 
4/5/10 

Defective Protein Is a Double Hit for Ataxia
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile